Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METAXALONE, with a corresponding US DMF Number 28062.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 14, 2014, and payment made on March 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II